🇺🇸 FDA
Pipeline program

SPR720

SPR720-201

Phase 2 small_molecule terminated

Quick answer

SPR720 for Mycobacterium Avium Complex is a Phase 2 program (small_molecule) at Spero Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Spero Therapeutics
Indication
Mycobacterium Avium Complex
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials